NEWS

September 10, 2020

FDA Approves Trelegy Ellipta as the First Once-Daily Single Inhaler Triple Therapy for the Treatment of Both Asthma and COPD in the US

August 31, 2020

Chiasma Announces U.S. Commercial Launch and Availability of MYCAPSSA®, the First and Only Oral Somatostatin Analog for Patients with Acromegaly

July 7, 2020

HCR Partners Announces Two New Appointments to Senior Advisor Board

June 26, 2020

Chiasma Announces FDA Approval of MYCAPSSA® (Octreotide) Capsules, the First and Only Oral Somatostatin Analog

June 22, 2020

Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

June 9, 2020

Albireo Announces Two Financing Transactions to Extend Cash Runway Into the Beginning of 2022

June 1, 2020

First Meeting with Ted Seides: Interview with Clarke Futch – HealthCare Royalty Partners

May 12, 2020

COVID-19 Private Financing

April 8, 2020

Chiasma Enters Into Revenue Interest Financing Agreement for up to $75 Million with Healthcare Royalty Partners

April 2, 2020

RedHill Biopharma Completes Acquisition of Movantik^® from AstraZeneca